Qiagen (QGEN) Tops Q4 EPS by 4c, Revenues Beat; Offers FY20 EPS Guidance Above Consensus

Go back to Qiagen (QGEN) Tops Q4 EPS by 4c, Revenues Beat; Offers FY20 EPS Guidance Above Consensus

QIAGEN Reports Results for Fourth Quarter and Full-Year 2019

February 4, 2020 4:05 PM EST

Delivers on Q4 2019 net sales outlook, exceeds on adjusted EPS Net sales of $413.5 million (+3% actual, +4% CER, vs. ~+3% CER outlook) Diluted EPS $0.19; adjusted EPS $0.48 ($0.48 CER, +20% CER vs. ~$0.45-0.46 CER outlook) Adjusted operating income margin rises to 33.5% of sales vs. 29.6% in Q4 2018 Achieves FY 2019 net sales outlook, exceeds on adjusted EPS Net sales of $1.53 billion (+2% actual, +4% CER, vs. ~+4% CER outlook) Net loss per share $0.18; adjusted EPS $1.43 ($1.46 CER, +9% CER vs. ~$1.43-1.44 CER outlook) Adjusted operating income... More